Evidence map›Paper›PMID 28828001›Full record

ArticleEXCLI journal2017

Structure-activity relationships and molecular docking studies of chromene and chromene based azo chromophores: A novel series of potent antimicrobial and anticancer agents.

Tarek H Afifi, Rawda M Okasha, Hany E A Ahmed, Janez Ilaš, Tarek Saleh, Alaa S Abd-El-Aziz

Abstract read
In one paragraph

Article in EXCLI journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Synthesis and Evaluation of Some New 4Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. A New Family of Benzo[International journal of molecular sciences · 2021
    Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tarek H AfifiChemistry Department, Faculty of Science, Taibah University, 30002, Al-Madinah Al-Munawarah, Saudi Arabia.
Rawda M OkashaChemistry Department, Faculty of Science, Taibah University, 30002, Al-Madinah Al-Munawarah, Saudi Arabia.
Hany E A AhmedPharmacognosy and Pharmaceutical Chemistry Department, Pharmacy College, Taibah University, Al-Madinah Al-Munawarah, Saudi Arabia.
Janez IlašFaculty of Pharmacy, University of Ljubljana, Aškerceva 7, 1000 Ljubljana, Slovenia.
Tarek SalehDepartment of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, N1G 2W1, Canada.
Alaa S Abd-El-AzizChemistry Department, Faculty of Science, University of Prince Edward Island, Charlottetown, Prince Edward Island C1A 4P3, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design of novel materials with significant biological properties is a main target in drug design research. Chromene compounds represent an interesting medicinal scaffold in drug replacement systems. This report illustrates a successful synthesis and characterization of two novel series of

Indexed as

2D QSAR and docking simulationsantitumor activitybiological applicationschromene azo dyeschromene compounds

Identifiers

PMID28828001
PMCPMC5547389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.